What is IPF?

Idiopathic pulmonary fibrosis (IPF) is a debilitating and almost uniformly fatal disease. Despite recent progress, the diagnosis and management of IPF remain distinct clinical challenges, further complicated by the rapid emergence of new data that challenge conventional wisdom and prompt a reexamination of standard therapeutic approaches. The aim of the PILOT™ initiative is to provide a forum for the open exchange of scientific ideas that results in the timely dissemination of emerging knowledge, facilitates clinical decision making, and improves patient outcomes.